Oramed Pharmaceuticals Inc. 13D and 13G filings for Nano Dimension Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-19 9:50 pm Purchase | 2026-02-17 | 13D | NANO DIMENSION LTD SPONSORED A NNDM | ORAMED PHARMACEUTICALS INC. ORMP | 10,942,087 5.200% | 392,657 (+3.72%) | Filing |
| 2026-01-29 4:44 pm Purchase | 2026-01-29 | 13D | NANO DIMENSION LTD SPONSORED A NNDM | ORAMED PHARMACEUTICALS INC. ORMP | 10,549,430 5.000% | 10,549,430 (New Position) | Filing |